ALLEROD, Denmark, Jan 30 (Reuters) - A play examining the meteoric rise of Danish weight-loss drug giant Novo Nordisk will premiere on Saturday at a theatre outside Copenhagen. "The Golden Calf" tells ...

Ozempic has been one of Novo Nordisk's (NYSE: NVO) main growth drivers for several years now and has practically become a ...

COPENHAGEN, Feb 4 () - Novo Nordisk CEO Mike ​Doustdar said on ‌Wednesday that the price reductions ‌for its obesity drug ...

COPENHAGEN, Feb 3 (Reuters) - Wegovy maker Novo Nordisk expects a decline in sales this year, it said on Tuesday, a new ...

Novo Nordisk threatens legal action against Hims & Hers for "duping" public with cheap compounds of its popular weight-loss ...

COPENHAGEN, Denmark, Jan. 15, 2026 /PRNewswire/ -- The Novo Nordisk Foundation has allocated up to DKK 5.5 billion (EUR 736 million) to BioInnovation Institute (BII), a leading institute for life ...

COPENHAGEN, Dec 4 (Reuters) - Denmark on Thursday sharply raised its economic growth forecast for 2025, due in part to the pharmaceuticals industry, which is performing well, its economy minister said ...

By Maggie Fick and Jacob Gronholt-Pedersen LONDON/COPENHAGEN, Feb 4 (Reuters) - Novo Nordisk's shares tumbled as much as 20% ...

Telehealth company Hims & Hers is launching a cheaper, off-brand version of the blockbuster weight loss pill Wegovy.

The Nature Index tracks primary research articles from 145 natural-science and health-science journals, chosen based on reputation by an independent group of researchers. The Nature Index provides ...

Bagsværd, Denmark and Plainsboro, NJ, 5 February 2026 – Novo Nordisk today issued the following statement regarding the announcement by Hims & Hers that they will unlawfully mass-market an unapproved, ...

The pharmaceutical giant expects sales to decline this year, potentially by double-digit percentages.